Genetic etiologies are responsible for seizures in up to 40% of children and 23% of adults with epilepsy.
1-7 Early use of genetic testing for diagnosis and clinical management has been proposed; however, recommendations for genetic testing in individuals with epilepsy are currently limited.
8-11 Additionally, estimates of how often a molecular diagnosis has clinically actionable implications have varied widely, from 60% in a single-center study
12 to 20% in a multicenter study,
13 although more recent studies estimate 50%.
6,14,15 Studies of treatment approaches based on genetic diagnoses have shown improved outcomes in patients with epilepsy.
1,5,7,12,16-19